Answers - Finance

Humans have a natural tendency to follow the crowd, but when timing the markets, following the crowd can often result in losses.

Unless you are in the middle of a long term trend, it usually d

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

oesn't work to conform to the masses.

Expert market timers know how to spot trends and they make sure to climb on board and profit. But often, the very same buy and sell decisions, which must

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

e executed to jump on board that trend, are in direct conflict with current market sentiment.

It is not easy to make that trade when it conflicts with what seemingly everyone else is doing.

I

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

terestingly, your ability to break away from what the masses are doing, from current sentiment, may have a lot to do with your personality.

Following The Crowd

There is safety and comfort in

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

umbers. In following the crowd. Across the generations, people learned that survival depended on banding together and working as a group.

All humans inherited this legacy, and it is shown in t

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

e security we feel when we follow the crowd.

The most successful members of society have seen the virtues in following the crowd. They have learned to look for rules to follow and to decide wh

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

ich standards to strive for. Blind obedience to authority may not be beneficial but compromise is.

To be successful, it was vital to protect one's self interests yet also stay within the bound

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

of acceptable behavior.

Although you've been frequently warned about the pitfalls of following the crowd, it's important to recognize that it is a survival instinct that is ingrained not only

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

in humans, but in most animals too. Think of herds of deer, flocks of birds, swarms of insects, schools of fish. There is safety in numbers.

Going Our Own Way

Although following the crowd isn

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

t bad all the time, such as during a long term rally, there are times when a market timer should not follow the crowd.

If all we had to do to be profitable was follow our instincts, we would l

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

kely be making the same buy and sell decisions as the vast majority of traders. But just as the vast majority of traders are NOT profitable... as market timers we want to "break away" from thei

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

r emotional trading and BE profitable.

Market timers trade market trends. Trends are created by the masses. Those same masses who are buying stocks at the top of a rally, and selling stocks at

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

the bottom of a correction.

This means that most of the time, as market timers, we must go our own way. And right there is the crux of the problem.

As soon as our timing strategy, which is NO

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

based on the emotions of the masses, issues a buy or sell signal contrary to the current sentiment, our very human survival instincts kick in. We want to STAY with the crowd. It is hard to do

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

hat your instincts tell you not to do.

But those market timers who are successful, have learned to do just that.

Breaking Away From The Masses

We WANT to follow the masses. It is comforting.

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

But if we want to profit when the masses do not, we must learn to push down those same instincts which have made us successful in life, and refuse to allow them to control our buy and sell dec

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

isions.

It is true that the crowd is often right... until a turning point occurs. But when the markets turn, the crowd holds on, often until most if not all their gains have evaporated.

Going

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

against the crowd takes a special kind of person, a person who isn't afraid of risk but doesn't seek it out, a person who looks inward only, and doesn't need reassurance from others.

FibTimer

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

as spent years developing and fine tuning market timing strategies that are profitable. Look at the historical trading results of individual trading strategies. These results can be yours, but

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ou must commit to trading the strategies for the months and years necessary to realize them.

Break away from the masses and you too can realize the profits that we have achieved over the years

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/102316/answers-Following-The-Crowd-To-Conform-Or-Not-To-Conform.html">Following The Crowd... To Conform Or Not To Conform?</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/102316/answers-Following-The-Crowd-To-Conform-Or-Not-To-Conform.html]Following The Crowd... To Conform Or Not To Conform?[/url]

The marketing paradigm that can literally make or break your coaching business. What's the single most important process determining whether or not your coaching business is successful?

How much of your actual catalogue should you make available online? How can a searchable product function increase your profit? Find out the answers to these and more question in this article.

Tags

Links

Answers - Following The Crowd... To Conform Or Not To Conform?

Related Articles: